ANROAlto Neuroscience, Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $30.00 · now $30.00 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ANRO has typically landed between $20.38 and $44.32 — a range of −32.1% to +47.7% from the issuance price $30.00.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

634 overlapping 1 month windows · 2024-02-022026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($30.00) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ANRO has typically landed a month from the 2026-09-16 close of $30 — the range is history, not a prediction.

$20.38worst · -32.1%$44.32best · +47.7%
  • now $30 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $31.62 (+5.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $26.25$36.98
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $20.38$44.32
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 634 windows spanning 2024-02-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2024-10-22−71.9%−74.5%+0.0%
2024-10-21−70.0%−74.0%+2.0%
2024-10-18−69.0%−74.3%+0.7%
3 best
2025-09-30+256.2%+0.0%+256.2%
2025-09-29+250.1%+0.0%+250.1%
2025-10-01+248.6%+0.0%+251.8%

634 overlapping windows · 2024-02-022026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~3 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
−5.8%
n=2
Feb
50%
−3.8%
n=2
Mar
33%
−3.0%
n=3
Apr
100%
+10.2%
n=3
May
33%
−13.7%
n=3
Jun
33%
+2.0%
n=3
Jul
100%
+14.3%
n=3
Aug
100%
+23.1%
n=3
Sep
33%
−5.6%
n=3
Oct
50%
+93.5%
n=2
Nov
50%
+5.5%
n=2
Dec
50%
+12.2%
n=2

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$37$3↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

98 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-05-27Miller Andrew CraigdirectorAward / grant26,00026,000Form 4
2026-05-14Etkin AmitdirectorGift400,000833,949Form 4
2026-05-12Manji HusseinidirectorAward / grant10,95810,958Form 4
2026-05-12Dreyfus AndrewdirectorAward / grant10,95810,958Form 4
2026-05-12Cox Christopher NixondirectorAward / grant10,95810,958Form 4
2026-05-12Sanchez RamirodirectorAward / grant10,95810,958Form 4
2026-05-12York GwilldirectorAward / grant10,95810,958Form 4
2026-03-01Etkin AmitdirectorWithheld for tax6,2271,233,949Form 4
2026-03-01Smith Nicholas ConradofficerWithheld for tax2,80624,060Form 4
2026-02-11Savitz AdamofficerAward / grant124,000124,000Form 4
2026-02-11Smith Nicholas ConradofficerAward / grant200,000200,000Form 4
2026-02-11Hanley Jr. Michael ConickofficerAward / grant131,000131,000Form 4
2026-02-11Etkin AmitdirectorAward / grant306,000306,000Form 4
2026-01-02Cox Christopher NixondirectorAward / grant7,1897,189Form 4
2026-01-02York GwilldirectorAward / grant5,2435,243Form 4
2026-01-02Manji HusseinidirectorAward / grant4,2284,228Form 4
2026-01-02Sanchez RamirodirectorAward / grant3,8063,806Form 4
2025-08-12Sanchez RamirodirectorAward / grant3,9283,928Form 4
2025-08-12Sanchez RamirodirectorAward / grant30,57430,574Form 4
2025-07-03Hanley Jr. Michael ConickofficerAward / grant8,0008,000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition8,0000Form 4
2025-07-03Hanley Jr. Michael ConickofficerAward / grant188,000188,000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition188,0000Form 4
2025-07-03Hanley Jr. Michael ConickofficerAward / grant125,000125,000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition125,0000Form 4
2025-07-03Savitz AdamofficerAward / grant22,48122,481Form 4
2025-07-03Savitz AdamofficerDisposition22,4810Form 4
2025-07-03Savitz AdamofficerAward / grant33,00833,008Form 4
2025-07-03Savitz AdamofficerDisposition33,0080Form 4
2025-07-03Savitz AdamofficerAward / grant123,645123,645Form 4
2025-07-03Savitz AdamofficerDisposition123,6450Form 4
2025-07-03Savitz AdamofficerAward / grant73,00073,000Form 4
2025-07-03Savitz AdamofficerDisposition73,0000Form 4
2025-07-03Savitz AdamofficerAward / grant76,00076,000Form 4
2025-07-03Savitz AdamofficerDisposition76,0000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition8,0000Form 4
2025-07-03Hanley Jr. Michael ConickofficerAward / grant188,000188,000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition188,0000Form 4
2025-07-03Hanley Jr. Michael ConickofficerAward / grant125,000125,000Form 4
2025-07-03Hanley Jr. Michael ConickofficerDisposition125,0000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.